Your browser doesn't support javascript.
loading
Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.
Hermanova, Ivana; Zúñiga-García, Patricia; Caro-Maldonado, Alfredo; Fernandez-Ruiz, Sonia; Salvador, Fernando; Martín-Martín, Natalia; Zabala-Letona, Amaia; Nuñez-Olle, Marc; Torrano, Verónica; Camacho, Laura; Lizcano, Jose M; Talamillo, Ana; Carreira, Suzanne; Gurel, Bora; Cortazar, Ana R; Guiu, Marc; López, Jose I; Martinez-Romero, Anabel; Astobiza, Ianire; Valcarcel-Jimenez, Lorea; Lorente, Mar; Arruabarrena-Aristorena, Amaia; Velasco, Guillermo; Gomez-Muñoz, Antonio; Suárez-Cabrera, Cristian; Lodewijk, Iris; Flores, Juana M; Sutherland, James D; Barrio, Rosa; de Bono, Johann S; Paramio, Jesús M; Trka, Jan; Graupera, Mariona; Gomis, Roger R; Carracedo, Arkaitz.
Afiliação
  • Hermanova I; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Zúñiga-García P; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Caro-Maldonado A; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Fernandez-Ruiz S; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Salvador F; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Martín-Martín N; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Zabala-Letona A; Cancer Science Program, Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Nuñez-Olle M; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Torrano V; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Camacho L; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Lizcano JM; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Talamillo A; Cancer Science Program, Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Carreira S; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Gurel B; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Cortazar AR; Biochemistry and Molecular Biology Department, University of the Basque Country, Bilbao, Spain.
  • Guiu M; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • López JI; Biochemistry and Molecular Biology Department, University of the Basque Country, Bilbao, Spain.
  • Martinez-Romero A; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Astobiza I; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Valcarcel-Jimenez L; The Institute of Cancer Research, London, UK.
  • Lorente M; The Institute of Cancer Research, London, UK.
  • Arruabarrena-Aristorena A; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Velasco G; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Gomez-Muñoz A; Cancer Science Program, Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Suárez-Cabrera C; Department of Pathology, Cruces University Hospital, Biocruces Institute, University of the Basque Country, Barakaldo, Spain.
  • Lodewijk I; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Flores JM; Vascular Signalling Laboratory, Program Against Cancer Therapeutic Resistance (ProCURE), Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain.
  • Sutherland JD; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Barrio R; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • de Bono JS; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Paramio JM; Department of Biochemistry and Molecular Biology, School of Biology, Complutense University, Madrid, Spain.
  • Trka J; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Graupera M; Department of Biochemistry and Molecular Biology, School of Biology, Complutense University, Madrid, Spain.
  • Gomis RR; Instituto de Investigaciones Sanitarias San Carlos, Madrid, Spain.
  • Carracedo A; Biochemistry and Molecular Biology Department, University of the Basque Country, Bilbao, Spain.
J Exp Med ; 217(6)2020 06 01.
Article em En | MEDLINE | ID: mdl-32219437
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Serina-Treonina Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Serina-Treonina Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article